Is it Possible to Screen for Type 2 Diabetes at Day 2 in Gestational Diabetes Mellitus Patients Postpartum?

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

51 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-06-30

Study Completion Date

2013-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Within 6 months of delivery, women who had gestational diabetes mellitus should be screened for type 2 diabetes with a fasting plasma glucose test and/or a 2-h postchallenge glycemia in a 75-g oral glucose tolerance test. However, not all women are screened. The objective of this study is to compare the screening test for type 2 diabetes done at 48 hours post-partum versus 8 weeks post-partum. The investigators want to measure the specificity, sensitivity, false and true predictive values of the screening test at 48 hours post-partum compared to the gold-standard.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Postpartum Screening of Type 2 Diabetes

NCT01869608

Type 2 Diabetes

COMPLETED NA

Screening Type 2 Diabetes Mellitus on the 2nd Day After Delivery in Women With Gestational Diabetes Mellitus

NCT02290860

Diabetes, Gestational

COMPLETED NA

Evaluating for Type-2 Diabetes in the Very Early Postpartum Period

NCT01988987

Diabetes, Gestational Prediabetic State Glucose Metabolism Disorders +1 more

COMPLETED

Oral Glucose Tolerance Testing After Gestational Diabetes

NCT02082301

Gestational Diabetes Pregnancy Obesity

COMPLETED

Early Screening for Gestational Diabetes Mellitus

NCT01026675

Gestational Diabetes Mellitus

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gestational Diabetes Mellitus Type 2 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Oral glucose tolerance test

oral glucose tolerance test performed 48 hours post-partum and 8 weeks post-partum.

Oral glucose tolerance test

Intervention Type PROCEDURE

Subjects will have the Oral glucose tolerance test 48 hours post-partum and the same test 8 weeks post-partum.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Oral glucose tolerance test

Subjects will have the Oral glucose tolerance test 48 hours post-partum and the same test 8 weeks post-partum.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Dx of gestational diabetes treated with insulin
* To be in post-partum
* Delivery of a baby of at least 37 weeks of gestation
* Have signed the consent form